did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780470978320

Chitosan-Based Systems for Biopharmaceuticals Delivery, Targeting and Polymer Therapeutics

by ;
  • ISBN13:

    9780470978320

  • ISBN10:

    0470978325

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2012-03-05
  • Publisher: Wiley

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

List Price: $218.61 Save up to $65.58
  • Rent Book $153.03
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    USUALLY SHIPS IN 3-4 BUSINESS DAYS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

Supplemental Materials

What is included with this book?

Summary

Chitosan is a linear polysaccharide produced commercially by the deacetylation of chitin. It is non-toxic, biodegradable, biocompatible, and acts as a bioadhesive with otherwise unstable biomolecules - making it a valuable component in the formulation of biopharmaceutical drugs. Chitosan-Based Systems for Biopharmaceuticals provides an extensive overview of the application of chitosan and its derivatives in the development and optimisation of biopharmaceuticals. The book is divided in four different parts. Part I discusses general aspects of chitosan and derivatives, with particular emphasis on issues related to the development of biopharmaceutical chitosan-based systems, comprising a useful background for the following chapters. Part II deals with the use of chitosan and derivatives in the formulation and delivery of biopharmaceuticals, and focuses on the synergistic effects between chitosan and this particular subset of pharmaceuticals. Part III continues and complements the previous part by discussing in detail specific applications of chitosan and/or some particular derivatives for biopharmaceutical use. Finally, Part IV presents diverse viewpoints on different issues such as regulatory, manufacturing and toxicological requirements of chitosan and its derivatives related with the development of biopharmaceutical products, as well as their patent status, and clinical application and potential. Topics covered include: chemical and technological advances in chitins and chitosans useful for the formulation of biopharmaceuticals physical properties of chitosan and derivatives in sol and gel states absorption promotion properties of chitosan and derivatives biocompatibility and biodegradation of chitosan and derivatives biological and pharmacological activity of chitosan and derivatives biological, chemical and physical compatibility of chitosan and biopharmaceuticals approaches for functional modification or crosslinking of chitosan use of chitosan and derivatives in conventional biopharmaceutical dosage forms formulation manufacture techniques of chitosan-based microparticles and nanoparticles for biopharmaceuticals chitosan and derivatives for biopharmaceutical use: mucoadhesive properties chitosan-based systems for mucosal delivery of biopharmaceuticals chitosan-based delivery systems for mucosal vaccination chitosan-based nanoparticulates for oral delivery of biopharmaceuticals chitosan-based systems for ocular delivery of biopharmaceuticals chemical modification of chitosan for delivery of DNA and siRNA target-specific chitosan-based nanoparticle systems for nucleic acid delivery functional PEGylated chitosan systems for biopharmaceuticals stimuli-sensitive chitosan-based systems for biopharmaceuticals chitosan copolymers for biopharmaceuticals application of chitosan for anti-cancer biopharmaceutical delivery chitosan-based biopharmaceuticals scaffolds in tissue engineering and re

Author Biography

Bruno Sarmento, Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal & CICS, Department of Pharmaceutical Sciences, Instituto Superior de Ciências da Saúde–Norte, Gandra, Portugal

José das Neves, Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal

Table of Contents

List of Contributorsp. xvii
Forewordp. xxiii
Prefacep. xxv
Acknowledgmentsp. xxvii
General Aspects of Chitosanp. 1
Chemical and Technological Advances in Chitins and Chitosans Useful for the Formulation of Biopharmaceuticalsp. 3
Introductionp. 3
Safety of Chitins and Chitosansp. 4
Ionic Liquids: New Solvents and Reaction Mediap. 5
Chitin and Chitosan Nanofibrilsp. 8
Electrospun Nanofibersp. 10
Polyelectrolyte Complexes and Mucoadhesionp. 12
Conclusions and Future Perspectivesp. 16
Physical Properties of Chitosan and Derivatives in Sol and Gel Statesp. 23
Introductionp. 23
Chitinp. 24
Chitosanp. 28
Conclusions and Future Perspectivesp. 36
Absorption Promotion Properties of Chitosan and Derivativesp. 45
Introductionp. 45
Effect of Chitosan on the Intestinal Absorption of Poorly Absorbable Drugsp. 47
Effect of Chitosan Derivatives on the Intestinal Absorption of Poorly Absorbable Drugsp. 47
Effect of Chitosan Oligomers on the Intestinal Absorption of Poorly Absorbable Drugsp. 48
Colon-Specific Delivery of Insulin Using Chitosan Capsulesp. 51
Conclusions and Future Perspectivesp. 54
Biocompatibility and Biodegradation of Chitosan and Derivativesp. 57
Introductionp. 57
Biocompatibility Evaluation of Chitosan and Derivativesp. 58
Biodegradation of Chitosan and Derivativesp. 65
Conclusions and Future Perspectivesp. 69
Biological and Pharmacological Activity of Chitosan and Derivativesp. 75
Introductionp. 75
Biological Activityp. 76
Chitosan's Usefulness in Therapy and Alternative Medicinep. 82
Conclusions and Future Perspectivesp. 84
Biological, Chemical, and Physical Compatibility of Chitosan and Biopharmaceuticalsp. 93
Introductionp. 93
Structural Features of Chitosan and Its Derivativesp. 94
Biocompatibility for Chitosan and Its Derivativesp. 95
Biocompatibility of Photo-Cross-Linkable Chitosan Hydrogelp. 98
Physical and Chemical Compatibility of Chitosan and Its Derivativesp. 100
Conclusions and Future Perspectivesp. 102
Approaches for Functional Modification or Cross-Linking of Chitosanp. 107
Introductionp. 107
General Awareness of Chitosan Cross-Linking Methodsp. 108
Modified Chitosan: Synthesis and Characterizationp. 112
Applications of Modified Chitosan and Its Derivatives in Drug Deliveryp. 118
Conclusions and Future Perspectivesp. 118
Biopharmaceuticals Formulation and Delivery Aspects Using Chitosan and Derivativesp. 125
Use of Chitosan and Derivatives in Conventional Biopharmaceutical Dosage Forms Formulationp. 127
Introductionp. 127
Advantageous Properties of Chitosan and Its Derivativesp. 128
Oral Administrationp. 129
Buccal Administrationp. 131
Nasal Administrationp. 132
Pulmonary Administrationp. 132
Transdermal Administrationp. 133
Conclusions and Future Perspectivesp. 133
Manufacture Techniques of Chitosan-Based Microparticles and Nanoparticles for Biopharmaceuticalsp. 137
Introductionp. 137
Water-in-Oil Emulsion and Chemical Cross-linkingp. 138
Drying Techniquesp. 141
Ionic Cross-linking Methodsp. 144
Coacervation and Precipitation Methodp. 151
Direct Interaction between Chitosan and Biopharmaceuticalsp. 152
Conclusions and Future Perspectivesp. 153
Chitosan and Derivatives for Biopharmaceutical Use: Mucoadhesive Propertiesp. 159
Introductionp. 159
Mucoadhesionp. 160
Chitosan and Its Derivativesp. 161
Biopharmaceutical Use of Chitosan and Its Derivativesp. 171
Conclusions and Future Perspectivesp. 175
Chitosan-Based Systems for Mucosal Delivery of Biopharmaceuticalsp. 181
Introductionp. 181
Important Challenges for the Delivery of Biopharmaceuticals by Mucosal Routesp. 182
Interest in Chitosan for Mucosal Delivery of Biopharmaceuticalsp. 184
Chitosan-Based Delivery Nanosystems for Mucosal Delivery of Biopharmaceuticalsp. 188
Conclusions and Future Perspectivesp. 200
Chitosan-Based Delivery Systems for Mucosal Vaccinationp. 211
Introductionp. 211
Adjuvant Properties of Chitosanp. 212
Chitosan in the Delivery of Protein and Subunit Vaccinesp. 213
Chitosan-Based Formulations of DNAVaccinesp. 215
Vaccine Formulations Using Chitosan in Combination with Other Polymersp. 216
Chitosan Derivatives in Vaccine Carrier Designp. 217
Conclusions and Future Perspectivesp. 220
Chitosan-Based Nanoparticulates for Oral Delivery of Biopharmaceuticalsp. 225
Introductionp. 225
Challenges on the Oral Delivery of Therapeutic Proteinsp. 226
Challenges on the Oral Delivery of Genetic Materialp. 227
Role of Chitosan in the Protection of Biopharmaceuticals in the Gastrointestinal Tractp. 229
Chitosan-Based Nanoparticles for Oral Delivery of Therapeutic Proteinsp. 232
Chitosan-Based Nanoparticles for Oral Delivery of Genetic Materialp. 234
Conclusions and Future Perspectivesp. 236
Chitosan-Based Systems for Ocular Delivery of Biopharmaceuticalsp. 243
Introductionp. 243
Ocular Delivery of Biopharmaceuticalsp. 244
Chitosan: A Suitable Biomaterial for Ocular Therapeuticsp. 244
Chitosan-Based Systems for Ocular Delivery of Biomacromoleculesp. 245
Toxicological and Compatibility Aspects of Chitosan-Based Ocular Systemsp. 249
Conclusions and Future Perspectivesp. 250
Chemical Modification of Chitosan for Delivery of DNA and siRNA5p. 25
Introductionp. 255
Hydrophilic Modificationp. 256
Hydrophobic Modificationp. 257
Specific Ligand Modificationp. 259
pH-Sensitive Modificationp. 264
Conclusions and Future Perspectivesp. 269
Advanced Application of Chitosan and Derivatives for Biopharmaceuticalsp. 275
Target-Specific Chitosan-Based Nanoparticle Systems for Nucleic Acid Deliveryp. 277
Introductionp. 277
Chitosan-Based Nanoparticle Delivery Systemsp. 283
Illustrative Examples of DNAVaccine Deliveryp. 286
Illustrative Examples of Nucleic Acid Delivery Systems for Cancer Therapyp. 288
Illustrative Examples of Nucleic Acid Delivery Systems for Anti-Inflammatory Therapyp. 291
Conclusions and Future Perspectivesp. 294
Functional PEGylated Chitosan Systems for Biopharmaceuticalsp. 301
Introductionp. 301
PEGylated Chitosan for the Delivery of Proteins and Peptidesp. 304
PEGylated Chitosan for Delivery of Nucleic Acidsp. 308
PEGylated Chitosan for Delivery of Other Macromolecular Biopharmaceuticalsp. 311
PEGylated Chitosan Used for Cellular Scaffoldsp. 313
Conclusions and Future Perspectivesp. 313
Stimuli-Sensitive Chitosan-Based Systems for Biopharmaceuticalsp. 319
Introductionp. 319
pH-Sensitive Chitosan-Based Systemsp. 319
Thermosensitive Chitosan-Based Systemsp. 321
pH-Sensitive and Thermosensitive Chitosan-Based Systemsp. 323
pH- and Ionic-Sensitive Chitosan-Based Systemsp. 325
Photo-Sensitive Chitosan-Based Systemsp. 325
Electrical-Sensitive Chitosan-Based Systemsp. 326
Magnetic-Sensitive Chitosan-Based Systemsp. 326
Chemical Substance-Sensitive Chitosan-Based Systemsp. 327
Conclusions and Future Perspectivesp. 327
Chitosan Copolymers for Biopharmaceuticalsp. 333
Introductionp. 333
Chitosan-g-Poly(Ethylene Glycol)p. 337
Chitosan-g-Polyethyleniminep. 347
Other Copolymers of Chitosanp. 357
Copolymers of Chitosan with Promising Applicationsp. 363
Conclusions and Future Perspectivesp. 368
Application of Chitosan for Anticancer Biopharmaceutical Deliveryp. 381
Introductionp. 381
Chitosan and Cancer: Intrinsic Antitumor Activity of the Polymer Itselfp. 382
Chitosan Formulations Developed for Classic Anticancer Drugsp. 383
Biopharmaceuticals Delivered by Chitosan Preparationsp. 384
Active Targeting Strategies and Multifunctional Chitosan Formulationsp. 388
Conclusions and Future Perspectivesp. 389
Chitosan-Based Biopharmaceutical Scaffolds in Tissue Engineering and Regenerative Medicinep. 393
Introductionp. 393
Fabrication of Chitosan-Based Biopharmaceuticals Scaffoldsp. 395
Applications of Chitosan-Based Biopharmaceutical Scaffolds in Tissue Engineering and Regenerative Medicinep. 403
Future Trends: Regenerative Engineeringp. 416
Conclusions and Future Perspectivesp. 417
Wound-Healing Properties of Chitosan and Its Use in Wound Dressing Biopharmaceuticalsp. 429
Introductionp. 429
Brief Review of Wound Repairp. 430
Wound-Healing Effects of Chitosanp. 433
Chitosan for Wound Therapeutics Deliveryp. 440
Conclusions and Future Perspectivesp. 444
Regulatory Status, Toxicological Issues, and Clinical Perspectivesp. 451
Toxicological Properties of Chitosan and Derivatives for Biopharmaceutical Applicationsp. 453
Introductionp. 453
In Vitro Toxicity of Chitosan and Derivativesp. 454
In Vivo Toxicity of Chitosan and Derivativesp. 457
Conclusions and Future Perspectivesp. 459
Regulatory Status of Chitosan and Derivativesp. 463
Introductionp. 463
Sourcep. 464
Characterizationp. 464
Purityp. 465
Applications of Advanced Uses of Chitosanp. 466
Regulatory Considerations for Chitosan and Chitosan Derivatives in the European Union, and Medical Devices or Combination Products with Medical Device (CDRH) Leadp. 468
Regulatory Pathwaysp. 469
Chitosan Medical Products: US Regulatory Review Processes for Medical Devices or Combination Products with CDRH Leadp. 469
Chitosan Wound Dressingsp. 470
The European Regulatory System: The European Medicines Agency (EMA) and European Directorate for the Quality of Medicines (EDQM)p. 474
Further Regulatory Considerationsp. 475
Conclusions and Future Perspectivesp. 477
Disclaimerp. 478
Patentability and Intellectual Property Issues Related to Chitosan-Based Biopharmaceutical Productsp. 483
Introductionp. 483
Setting the Scene: The Role of Chitosan as a Pharmaceutical Excipientp. 484
Addressing the Drivers for Scientific Progress on Chitosan: Innovation and Inventabilityp. 495
Conclusions and Future Perspectivesp. 496
Quality Control and Good Manufacturing Practice (GMP) for Chitosan-Based Biopharmaceutical Productsp. 503
Introductionp. 504
Regulatory Requirements for Productionp. 505
Manufacturing GMP: Fundamental Considerationsp. 508
Requirements for Rooms, Personnel, and Equipmentp. 511
Qualification and Validationp. 511
Quality Controlp. 513
Monitoring and Maintenance of a GMP Systemp. 519
Conclusions and Future Perspectivesp. 522
Preclinical and Clinical Use of Chitosan and Derivatives for Biopharmaceuticals: From Preclinical Research to the Bedsidep. 525
Introductionp. 525
Chitosan as a Parenteral (Subcutaneous) Vaccine Platformp. 526
Chitosan as an Immunotherapeutic Platformp. 530
Conclusions and Future Perspectivesp. 537
Referencesp. 539
Indexp. 543
Table of Contents provided by Publisher. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program